SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Taipale H, Hamina A, Karttunen N, Koponen M, Tanskanen A, Tiihonen J, Hartikainen S, Tolppanen AM. Pain 2019; 160(2): 417-423.

Affiliation

Research Centre for Comparative Effectiveness and Patient Safety (RECEPS), University of Eastern Finland, PO Box 1627, 70211 Kuopio, Finland.

Copyright

(Copyright © 2019, Lippincott, Williams and Wilkins)

DOI

10.1097/j.pain.0000000000001412

PMID

30325873

Abstract

The objective of this study was to investigate whether incident opioid use is associated with an increased risk of hip fractures among community-dwelling persons with Alzheimer's disease (AD), and to assess the association in terms of duration of use and opioid strength.Among community-dwelling persons with AD diagnosed in 2010-2011 (N=23,100), a matched cohort study comparing incident opioid users (N=4,750) to opioid nonusers (N=4,750) was constructed. Matching was based on age, gender and time since AD diagnosis at opioid initiation. Data on drug use and hip fractures were retrieved from nationwide registers. Incident opioid users were identified with a one-year washout. Cox proportional hazard models compared the risk of hip fracture between opioid use and nonuse, and were weighted with inverse probability of treatment (IPT), based on a propensity score.Age-adjusted incidence rate of hip fractures was 3.47 (95% CI 2.62-4.33) during opioid use and 1.94 (95% CI 1.65-2.22) during nonuse. Opioid use was associated with an increased risk of hip fracture (IPT-weighted HR 1.96, 95% CI 1.27-3.02). The risk was observed during the first two months of use (IPT-weighted HR 2.37, 1.04-5.41) and attenuated after that. The results suggest an increase in the risk of hip fracture by increasing opioid strength; weak opioids IPT-weighted HR 1.75 (0.91-3.35), buprenorphine IPT-weighted HR 2.10 (1.41-3.13) and strong opioids IPT-weighted HR 2.89 (1.32-6.32).Further research is needed to find out if the risk of injurious falls is avoidable by slow titration of opioid doses in the beginning of treatment.


Language: en

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print